8-K - Elicio Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On November 13, 2025, Elicio Therapeutics, Inc. (the “Company”) announced its financial results for the quarter e

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Press Release dated November 13, 2025. 104 Cover Page Interactive Data

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1